We are live on ! Find out more
ICCM icon

IceCure Medical

9 hedge funds and large institutions have $172K invested in IceCure Medical in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.07% less ownership

Funds ownership: 0.08%0.01% (-0.07%)

31% less funds holding

Funds holding: 139 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

100% less capital invested

Capital invested by funds: $54.8M → $172K (-$54.6M)

Holders
9
Holders Change
-4
Holders Change %
-30.77%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
8
Calls
Puts
Net Calls
Net Calls Change

ICCM Hedge Fund Activity: Q1 2022 in Review

9 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q1 2022, worth a combined $172K — down 100% from $54.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ICCM and 4 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $37.2K. The largest seller was Credit Suisse, exiting entirely with an estimated $52.5M sold.

  • 9 institutional investors held IceCure Medical (ICCM) as of Q1 2022, down from 13 in Q4 2021.
  • Funds reported $172K of IceCure Medical stock for Q1 2022, down 100% quarter-over-quarter.
  • 4 funds opened new IceCure Medical positions in Q1 2022 and 8 closed out, a net change of -4 holders.
  • The largest IceCure Medical buyer in Q1 2022 was Citadel Advisors, an estimated $37.2K added.
  • The largest IceCure Medical seller in Q1 2022 was Credit Suisse, an estimated $52.5M sold.

Based on aggregated 13F filings for Q1 2022.